Document ID: chunk:federal_register_of_legislation:F2021L01325:clause:2_7
Version: federal_register_of_legislation:F2021L01325
Segment Type: clause
Provision Reference: sch 2 cl 7
Character Range: 4767–5630

7  Transitional arrangements
 (1) In this section:
  former instrument means the Therapeutic Goods Order No. 87 General requirements for the labelling of biologicals, as in force immediately before the commencement of the repeal instrument.
  repeal instrument means the Therapeutic Goods (Standards for Biologicals) Repeal Instrument 2021.
  transition period means the period beginning on 30 September 2021 and ending on 30 September 2022.
 (2) Despite the repeal of the former instrument by the repeal instrument, the former instrument continues to apply for the duration of the transition period, such that the standard for biologicals in relation to labelling constituted by the former instrument may be conformed with as an alternative to the standard for biologicals in relation to labelling constituted by this instrument.

Part 2Labelling requirements